Nonetheless, additional data suggest that metabolic syndrome, insulin resistance, and diabetic complications are linked to elevated PRL serum levels in T2DM patients (which is a risk factor for T2DM) (Duc Nguyen et al., 2022). This evidence concerns the gene PRL and Insulin resistance.